English

NPS PHARMACEUTICALS INC

EDGAR

Annual report amendment (10-K/A) · filed 2015-02-23

98 filing records in this dataset, filed from 1996-05-14 to 2015-02-23. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

66.7 million USD

2014 Q4 · USD

Exact inputs and evidence

Revenue: 66695000 USD Source

Operating margin

1.28%

2014 Q4 · %

Exact inputs and evidence

Operating Income: 857000 USD Source
Revenue: 66695000 USD Source

Operating cash flow

-4.39 million USD

2014 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -16710000 USD Source
Operating Cash Flow: -12317000 USD Source

Cash and cash equivalents: 65.6 million USD 2014-12-31 Source
Exact value

65565000 USD
Long-term debt including current maturities: 100 million USD 2014-12-31 Source
Exact value

100006000 USD
Shares outstanding: 107 million sharesItemType 2014-12-31 Source
Exact value

107103262 sharesItemType

Reported share-count change

4.38% · 4.49 million sharesItemType

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

102613780 sharesItemType · 2013-12-31· Source
107103262 sharesItemType · 2014-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

224 million USD

2014-01-01 – 2014-12-31

Exact inputs and evidence

Revenue: 44040000 USD · 2014-01-01 – 2014-03-31 Source
Revenue: 56127000 USD · 2014-04-01 – 2014-06-30 Source
Revenue: 57200000 USD · 2014-07-01 – 2014-09-30 Source
Revenue: 66695000 USD · 2014-10-01 – 2014-12-31 Source

Net income

-8.71 million USD

2014-01-01 – 2014-12-31

Exact inputs and evidence

Net income: -6576000 USD · 2014-01-01 – 2014-03-31 Source
Net income: 1992000 USD · 2014-04-01 – 2014-06-30 Source
Net income: -2146000 USD · 2014-07-01 – 2014-09-30 Source
Net income: -8705000 USD · 2014-01-01 – 2014-12-31 Source
Net income: -6730000 USD · 2014-01-01 – 2014-09-30 Source

Operating cash flow

-16.7 million USD

2014-01-01 – 2014-12-31

Exact inputs and evidence

Operating cash flow: -6670000 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: -12749000 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: -6670000 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: -12317000 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: -12749000 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: -16710000 USD · 2014-01-01 – 2014-12-31 Source
Operating cash flow: -12317000 USD · 2014-01-01 – 2014-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2015-02-23.

Financial data available through: 2014-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2014-12-31
Operating income: 9 of 11 periods available· newest 2014-12-31
Net income: 8 of 11 periods available· newest 2014-12-31
Operating cash flow: 9 of 11 periods available· newest 2014-12-31
capital expenditure: No compatible figures in this window
Total assets: 7 of 11 periods available· newest 2014-12-31
Total liabilities: 9 of 11 periods available· newest 2014-12-31
Current assets: 9 of 11 periods available· newest 2014-12-31
Current liabilities: 9 of 11 periods available· newest 2014-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2014-12-31
Long-term debt including current maturities: 4 of 11 periods available· newest 2014-12-31
Shares outstanding: 5 of 11 periods available· newest 2014-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+44%

Prior period

USD 155.59 million

2013-01-01 – 2013-12-31
Current period

USD 224.06 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

224062000 − 155592000 = 68470000 USD

155592000 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
224062000 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NPS PHARMACEUTICALS INC · 2014-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Year-over-year change in Revenue: 68470000 USD Concept: fundies:Revenue Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 224062000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626115000049/npsp-20141231.xml#165162 Filing: 000113626115000049 Input fundies:Revenue: 155592000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626115000049/npsp-20141231.xml#165281 Filing: 000113626115000049
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 4.8 million

Prior period

−USD 13.5 million

2013-01-01 – 2013-12-31
Current period

−USD 8.71 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

-8705000 − -13504000 = 4799000 USD

-13504000 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
-8705000 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NPS PHARMACEUTICALS INC · 2014-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Year-over-year change in Net income: 4799000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -8705000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626115000049/npsp-20141231.xml#167659 Filing: 000113626115000049 Input fundies:NetIncome: -13504000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626115000049/npsp-20141231.xml#167787 Filing: 000113626115000049
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 7.61 million

Prior period

−USD 24.32 million

2013-01-01 – 2013-12-31
Current period

−USD 16.71 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

-16710000 − -24316000 = 7606000 USD

-24316000 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
-16710000 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NPS PHARMACEUTICALS INC · 2014-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Year-over-year change in Operating cash flow: 7606000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -16710000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626115000049/npsp-20141231.xml#178771 Filing: 000113626115000049 Input fundies:OperatingCashFlow: -24316000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626115000049/npsp-20141231.xml#178998 Filing: 000113626115000049
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2014 2014-01-01 – 2014-12-31

Revenue USD 224.06 million 100% of revenue
Cost of revenue USD 14.65 million 6.5% of revenue
Operating expenses USD 204.36 million 91% of revenue
Operating income USD 5.05 million 2.3% of revenue
Tax, interest and other Derived USD 13.76 million 6.1% of revenue
Net income −USD 8.71 million −3.9% of revenue

Cash

Operating cash flow −USD 16.71 million −7.5% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2004 Operating loss: operating costs were 1,259% of revenue.
2005 Operating loss: operating costs were 1,304% of revenue.
2006 Operating loss: operating costs were 292% of revenue.
2009 Not shown: operating income or net income is not reported.
2010 Net loss: net income was −35% of revenue.
2011 Net loss: net income was −36% of revenue.
2012 Operating loss: operating costs were 101% of revenue.
2013 Operating loss: operating costs were 101% of revenue.
2014 Net loss: net income was −3.9% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2004 2004-01-01 – 2004-12-31	14237000	179285000 Derived	-165048000	3203000 Derived	-168251000	Unavailable	Source 2004-01-01 – 2004-12-31: 14237000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -165048000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -168251000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -148117000 USD Inspect Operating Cash Flow Open source
2005 2005-01-01 – 2005-12-31	12825000	167224000 Derived	-154399000	15324000 Derived	-169723000	Unavailable	Source 2005-01-01 – 2005-12-31: 12825000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -154399000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -169723000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -161414000 USD Inspect Operating Cash Flow Open source
2006 2006-01-01 – 2006-12-31	48502000	141441000 Derived	-92939000	19729000 Derived	-112668000	Unavailable	Source 2006-01-01 – 2006-12-31: 48502000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -92939000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -112668000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -103912000 USD Inspect Operating Cash Flow Open source
2009 2009-01-01 – 2009-12-31	84147000	56447000 Derived	27700000	Unavailable	Unavailable	Unavailable	Source 2009-01-01 – 2009-12-31: 84147000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 27700000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -1427000 USD Inspect Operating Cash Flow Open source
2010 2010-01-01 – 2010-12-31	89414000	79840000 Derived	9574000	41015000 Derived	-31441000	Unavailable	Source 2010-01-01 – 2010-12-31: 89414000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 9574000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -31441000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -17732000 USD Inspect Operating Cash Flow Open source
2011 2011-01-01 – 2011-12-31	101645000	101100000 Derived	545000	36812000 Derived	-36267000	Unavailable	Source 2011-01-01 – 2011-12-31: 101645000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 545000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -36267000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -56658000 USD Inspect Operating Cash Flow Open source
2012 2012-01-01 – 2012-12-31	130644000	131768000 Derived	-1124000	17611000 Derived	-18735000	Unavailable	Source 2012-01-01 – 2012-12-31: 130644000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -1124000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -18735000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -60992000 USD Inspect Operating Cash Flow Open source
2013 2013-01-01 – 2013-12-31	155592000	157087000 Derived	-1495000	12009000 Derived	-13504000	Unavailable	Source 2013-01-01 – 2013-12-31: 155592000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -1495000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -13504000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -24316000 USD Inspect Operating Cash Flow Open source
2014 2014-01-01 – 2014-12-31	224062000	219012000 Derived	5050000	13755000 Derived	-8705000	Unavailable	Source 2014-01-01 – 2014-12-31: 224062000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: 5050000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -8705000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -16710000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 224.1M 2014

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Revenue	14237000	Revenue: 14237000 Open source
20052005-12-31	Revenue	12825000	Revenue: 12825000 Open source
20062006-12-31	Revenue	48502000	Revenue: 48502000 Open source
20092009-12-31	Revenue	84147000	Revenue: 84147000 Open source
20102010-12-31	Revenue	89414000	Revenue: 89414000 Open source
20112011-12-31	Revenue	101645000	Revenue: 101645000 Open source
20122012-12-31	Revenue	130644000	Revenue: 130644000 Open source
20132013-12-31	Revenue	155592000	Revenue: 155592000 Open source
20142014-12-31	Revenue	224062000	Revenue: 224062000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

44% 2014

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Year over year	No prior comparable period	Revenue: 14237000 Open source
20052005-12-31	Year over year	-9.9%	Revenue: 12825000 Open source Revenue: 14237000 Open source
20062006-12-31	Year over year	278.2%	Revenue: 48502000 Open source Revenue: 12825000 Open source
20092009-12-31	Year over year	No prior comparable period	Revenue: 84147000 Open source
20102010-12-31	Year over year	6.3%	Revenue: 89414000 Open source Revenue: 84147000 Open source
20112011-12-31	Year over year	13.7%	Revenue: 101645000 Open source Revenue: 89414000 Open source
20122012-12-31	Year over year	28.5%	Revenue: 130644000 Open source Revenue: 101645000 Open source
20132013-12-31	Year over year	19.1%	Revenue: 155592000 Open source Revenue: 130644000 Open source
20142014-12-31	Year over year	44%	Revenue: 224062000 Open source Revenue: 155592000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 2.3% 2014

Net margin -3.9% 2014

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Operating margin	-1,159.3%	Operating Income: -165048000 Open source Revenue: 14237000 Open source
20052005-12-31	Operating margin	-1,203.9%	Operating Income: -154399000 Open source Revenue: 12825000 Open source
20062006-12-31	Operating margin	-191.6%	Operating Income: -92939000 Open source Revenue: 48502000 Open source
20092009-12-31	Operating margin	32.9%	Operating Income: 27700000 Open source Revenue: 84147000 Open source
20102010-12-31	Operating margin	10.7%	Operating Income: 9574000 Open source Revenue: 89414000 Open source
20112011-12-31	Operating margin	0.5%	Operating Income: 545000 Open source Revenue: 101645000 Open source
20122012-12-31	Operating margin	-0.9%	Operating Income: -1124000 Open source Revenue: 130644000 Open source
20132013-12-31	Operating margin	-1%	Operating Income: -1495000 Open source Revenue: 155592000 Open source
20142014-12-31	Operating margin	2.3%	Operating Income: 5050000 Open source Revenue: 224062000 Open source
20042004-12-31	Net margin	-1,181.8%	Net Income: -168251000 Open source Revenue: 14237000 Open source
20052005-12-31	Net margin	-1,323.4%	Net Income: -169723000 Open source Revenue: 12825000 Open source
20062006-12-31	Net margin	-232.3%	Net Income: -112668000 Open source Revenue: 48502000 Open source
2009-12-31	Net margin	Not reported	Revenue: 84147000 Open source
20102010-12-31	Net margin	-35.2%	Net Income: -31441000 Open source Revenue: 89414000 Open source
20112011-12-31	Net margin	-35.7%	Net Income: -36267000 Open source Revenue: 101645000 Open source
20122012-12-31	Net margin	-14.3%	Net Income: -18735000 Open source Revenue: 130644000 Open source
20132013-12-31	Net margin	-8.7%	Net Income: -13504000 Open source Revenue: 155592000 Open source
20142014-12-31	Net margin	-3.9%	Net Income: -8705000 Open source Revenue: 224062000 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 14237000 Open source Operating Cash Flow: -148117000 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 12825000 Open source Operating Cash Flow: -161414000 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 48502000 Open source Operating Cash Flow: -103912000 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 84147000 Open source Operating Cash Flow: -1427000 Open source
20102010-12-31	Free cash flow margin	Not reported	Revenue: 89414000 Open source Operating Cash Flow: -17732000 Open source
20112011-12-31	Free cash flow margin	Not reported	Revenue: 101645000 Open source Operating Cash Flow: -56658000 Open source
20122012-12-31	Free cash flow margin	Not reported	Revenue: 130644000 Open source Operating Cash Flow: -60992000 Open source
20132013-12-31	Free cash flow margin	Not reported	Revenue: 155592000 Open source Operating Cash Flow: -24316000 Open source
20142014-12-31	Free cash flow margin	Not reported	Revenue: 224062000 Open source Operating Cash Flow: -16710000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -16.7M 2014

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Operating cash flow	-148117000	Operating Cash Flow: -148117000 Open source
20052005-12-31	Operating cash flow	-161414000	Operating Cash Flow: -161414000 Open source
20062006-12-31	Operating cash flow	-103912000	Operating Cash Flow: -103912000 Open source
20092009-12-31	Operating cash flow	-1427000	Operating Cash Flow: -1427000 Open source
20102010-12-31	Operating cash flow	-17732000	Operating Cash Flow: -17732000 Open source
20112011-12-31	Operating cash flow	-56658000	Operating Cash Flow: -56658000 Open source
20122012-12-31	Operating cash flow	-60992000	Operating Cash Flow: -60992000 Open source
20132013-12-31	Operating cash flow	-24316000	Operating Cash Flow: -24316000 Open source
20142014-12-31	Operating cash flow	-16710000	Operating Cash Flow: -16710000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Free cash flow	Unavailable	Operating Cash Flow: -148117000 Open source
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: -161414000 Open source
20062006-12-31	Free cash flow	Unavailable	Operating Cash Flow: -103912000 Open source
20092009-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1427000 Open source
20102010-12-31	Free cash flow	Unavailable	Operating Cash Flow: -17732000 Open source
20112011-12-31	Free cash flow	Unavailable	Operating Cash Flow: -56658000 Open source
20122012-12-31	Free cash flow	Unavailable	Operating Cash Flow: -60992000 Open source
20132013-12-31	Free cash flow	Unavailable	Operating Cash Flow: -24316000 Open source
20142014-12-31	Free cash flow	Unavailable	Operating Cash Flow: -16710000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

53.8% 2014

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Liabilities / assets	103.2%	Total Liabilities: 410274000 Open source Total Assets: 397485000 Open source
20052005-12-31	Liabilities / assets	Not reported	Total Liabilities: 428576000 Open source
20062006-12-31	Liabilities / assets	Not reported	Total Liabilities: 417984000 Open source
20092009-12-31	Liabilities / assets	239.6%	Total Liabilities: 382391000 Open source Total Assets: 159592000 Open source
20102010-12-31	Liabilities / assets	167.8%	Total Liabilities: 384180000 Open source Total Assets: 228905000 Open source
20112011-12-31	Liabilities / assets	121.6%	Total Liabilities: 260096000 Open source Total Assets: 213980000 Open source
20122012-12-31	Liabilities / assets	136.2%	Total Liabilities: 205750000 Open source Total Assets: 151109000 Open source
20132013-12-31	Liabilities / assets	64.1%	Total Liabilities: 187332000 Open source Total Assets: 292222000 Open source
20142014-12-31	Liabilities / assets	53.8%	Total Liabilities: 155792000 Open source Total Assets: 289617000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.61× 2014

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Current assets / current liabilities	8.1×	Current Assets: 349491000 Open source Current Liabilities: 43142000 Open source
20052005-12-31	Current assets / current liabilities	7.08×	Current Assets: 272366000 Open source Current Liabilities: 38459000 Open source
20062006-12-31	Current assets / current liabilities	4.27×	Current Assets: 189689000 Open source Current Liabilities: 44467000 Open source
20092009-12-31	Current assets / current liabilities	1.96×	Current Assets: 145252000 Open source Current Liabilities: 73972000 Open source
20102010-12-31	Current assets / current liabilities	2.63×	Current Assets: 215895000 Open source Current Liabilities: 82145000 Open source
20112011-12-31	Current assets / current liabilities	4.58×	Current Assets: 199628000 Open source Current Liabilities: 43603000 Open source
20122012-12-31	Current assets / current liabilities	4.64×	Current Assets: 137051000 Open source Current Liabilities: 29567000 Open source
20132013-12-31	Current assets / current liabilities	4.43×	Current Assets: 258752000 Open source Current Liabilities: 58414000 Open source
20142014-12-31	Current assets / current liabilities	4.61×	Current Assets: 256445000 Open source Current Liabilities: 55633000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2004 2004-01-01 – 2004-12-31	−USD 168.25 million Exact value Exact value: -168251000 USD 2004-01-01 – 2004-12-31: -168251000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NPS PHARMACEUTICALS INC · 2004-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Net Income: -168251000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -168251000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/0001193125-07-054452.txt#8859 The citation records this snapshot. The page link may show a newer release later.	−USD 148.12 million Exact value Exact value: -148117000 USD 2004-01-01 – 2004-12-31: -148117000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NPS PHARMACEUTICALS INC · 2004-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Operating Cash Flow: -148117000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -148117000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/0001193125-07-054452.txt#9111 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	−USD 169.72 million Exact value Exact value: -169723000 USD 2005-01-01 – 2005-12-31: -169723000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NPS PHARMACEUTICALS INC · 2005-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Net Income: -169723000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -169723000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/0001193125-07-054452.txt#8859 The citation records this snapshot. The page link may show a newer release later.	−USD 161.41 million Exact value Exact value: -161414000 USD 2005-01-01 – 2005-12-31: -161414000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NPS PHARMACEUTICALS INC · 2005-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Operating Cash Flow: -161414000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -161414000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/0001193125-07-054452.txt#9111 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 112.67 million Exact value Exact value: -112668000 USD 2006-01-01 – 2006-12-31: -112668000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NPS PHARMACEUTICALS INC · 2006-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Net Income: -112668000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -112668000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/0001193125-07-054452.txt#8859 The citation records this snapshot. The page link may show a newer release later.	−USD 103.91 million Exact value Exact value: -103912000 USD 2006-01-01 – 2006-12-31: -103912000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NPS PHARMACEUTICALS INC · 2006-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Operating Cash Flow: -103912000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -103912000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/0001193125-07-054452.txt#9111 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	Unavailable Not reported for this period.	−USD 1.43 million Exact value Exact value: -1427000 USD 2009-01-01 – 2009-12-31: -1427000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NPS PHARMACEUTICALS INC · 2009-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Operating Cash Flow: -1427000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1427000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626112000104/npsp-20111231.xml#247299 Filing: 000113626112000104 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 31.44 million Exact value Exact value: -31441000 USD 2010-01-01 – 2010-12-31: -31441000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NPS PHARMACEUTICALS INC · 2010-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Net Income: -31441000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31441000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626113000114/npsp-20121231.xml#732170 Filing: 000113626113000114 The citation records this snapshot. The page link may show a newer release later.	−USD 17.73 million Exact value Exact value: -17732000 USD 2010-01-01 – 2010-12-31: -17732000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NPS PHARMACEUTICALS INC · 2010-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Operating Cash Flow: -17732000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17732000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626113000114/npsp-20121231.xml#303139 Filing: 000113626113000114 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2011 2011-01-01 – 2011-12-31	−USD 36.27 million Exact value Exact value: -36267000 USD 2011-01-01 – 2011-12-31: -36267000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NPS PHARMACEUTICALS INC · 2011-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Net Income: -36267000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -36267000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626114000082/npsp-20131231.xml#445139 Filing: 000113626114000082 The citation records this snapshot. The page link may show a newer release later.	−USD 56.66 million Exact value Exact value: -56658000 USD 2011-01-01 – 2011-12-31: -56658000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NPS PHARMACEUTICALS INC · 2011-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Operating Cash Flow: -56658000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -56658000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626114000082/npsp-20131231.xml#315318 Filing: 000113626114000082 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 18.74 million Exact value Exact value: -18735000 USD 2012-01-01 – 2012-12-31: -18735000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NPS PHARMACEUTICALS INC · 2012-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Net Income: -18735000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18735000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626115000049/npsp-20141231.xml#167916 Filing: 000113626115000049 The citation records this snapshot. The page link may show a newer release later.	−USD 60.99 million Exact value Exact value: -60992000 USD 2012-01-01 – 2012-12-31: -60992000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NPS PHARMACEUTICALS INC · 2012-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Operating Cash Flow: -60992000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -60992000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626115000049/npsp-20141231.xml#179225 Filing: 000113626115000049 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	−USD 13.5 million Exact value Exact value: -13504000 USD 2013-01-01 – 2013-12-31: -13504000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NPS PHARMACEUTICALS INC · 2013-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Net Income: -13504000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13504000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626115000049/npsp-20141231.xml#167787 Filing: 000113626115000049 The citation records this snapshot. The page link may show a newer release later.	−USD 24.32 million Exact value Exact value: -24316000 USD 2013-01-01 – 2013-12-31: -24316000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NPS PHARMACEUTICALS INC · 2013-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Operating Cash Flow: -24316000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24316000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626115000049/npsp-20141231.xml#178998 Filing: 000113626115000049 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2014-01-01 – 2014-12-31	−USD 8.71 million Exact value Exact value: -8705000 USD 2014-01-01 – 2014-12-31: -8705000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NPS PHARMACEUTICALS INC · 2014-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Net Income: -8705000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8705000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626115000049/npsp-20141231.xml#167659 Filing: 000113626115000049 The citation records this snapshot. The page link may show a newer release later.	−USD 16.71 million Exact value Exact value: -16710000 USD 2014-01-01 – 2014-12-31: -16710000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NPS PHARMACEUTICALS INC · 2014-12-31 NPS PHARMACEUTICALS INC (edgar:890465) Operating Cash Flow: -16710000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:44:28Z Snapshot: 825771156090d592f28ef5ed798d1f7b607de02a64bd6a7d88518c7ee0e883af Dimensions: Consolidated View: https://fundies.io/companies/edgar/890465/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16710000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/890465/000113626115000049/npsp-20141231.xml#178771 Filing: 000113626115000049 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

98 filings · 1,506 latest values · 1,506 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000890465, 890465, edgar:890465

Also known as NPS PHARMACEUTICALS INC

NPS PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2014 2014-01-01 – 2014-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation